Biologics Inspection Program

The Biologics Inspection Program ensures that products derived from living organisms, like vaccines and blood components, meet high standards of safety, effectiveness, and quality. Managed by regulatory authorities, it involves routine inspections of manufacturing facilities to ensure compliance with regulations. Inspectors evaluate processes, equipment, and overall practices to protect public health. The goal is to prevent contamination and ensure that biologics are safe for patients, ultimately promoting trust in these critical medical products.